pr
play

Pr an antiviral platform an immune enhancement platform Eh - PDF document

Sep 05, 2023 •433 likes •469 views

COMPANY SUMMARY BIO Boston 1x1 meeting ABIVAX ___________ MISSION NAME OF THE CEO ABIVAX is a biotechnology company harnessing the immune system to develop a functional cure for HIV and treatments for inflammatory diseases and cancer. Prof

  2. COMPANY SUMMARY BIO Boston 1x1 meeting ABIVAX ___________ MISSION NAME OF THE CEO ABIVAX is a biotechnology company harnessing the immune system to develop a functional cure for HIV and treatments for inflammatory diseases and cancer. Prof Hartmut Ehrlich, M.D. TECHNOLOGY ABIVAX leverages three technology platforms for drug discovery: Pr • an antiviral platform • an immune enhancement platform Eh • a polyclonal antibody platform Ch ALLIANCES/PARTNERSHIPS Of Partnerships • CNRS / Curie Institute Licenses • Scripps Research Institute ADDRESS UPCOMING CATALYSTS 5 rue de la Baume, 75008 Paris key operational milestones Q1 2019 ___________________ Candidate Q2 2018 Q3 2018 Q4 2018 EMAIL ABX464 IND 1 FSI 2 Topline data info@abivax.com Filing 005-study Phase IIb HIV www.abivax.com ABX464 Topline data IND FSI 101-study Filing Phase IIb UC MANAGEMENT TEAM CEO: Prof. Hartmut Ehrlich, M.D. ABX196 IND FSI HCC- CFO: Didier Blondel HCC Filing Phase I/II CMO: Jean-Marc Steens, M.D. CCO & VP BD : Pierre Courteille MARKET FIGURES R evenues 2017: 0 € TARGETED Date of IPO: June 2015 MARKET Ticker: ABVX.PA Exchange: Euronext Paris ____________ Currency: € Market cap: 72 million € (as of May 3, 2018) • HIV: Towards a functional cure for Price: 7.33 € (as of May 3, 2018) HIV: Targeting RNA splicing 52-weeks-high: 18.76 € • IBD (Ulcerative Colitis & Crohn’s 52-weeks-low: 7 € Disease) Average daily volume: 52000 per day in 2017 • Immuno-oncology in HCC in KEY FIGURES combination with checkpoint inhibitors € m 2016 2017 Growth (%) Sales 0 0 0% LISTED COMPANY EBIT -18 -14 22% Net Income -14 -11 21% CREATION DATE Cash Position 17 23 -26% December 2013

  3. COMPANY SUMMARY BIO Boston 1x1 meeting ABIVAX ___________ NAME OF THE CEO ANALYST COVERAGE Prof Hartmut Ehrlich, M.D. Broker Date Reco. Target Price Potential (%) Pr (buy/neutral/hold) NIBC 03/2018 Buy 15,10 € +106% Eh Goetz Partners 10/2017 Buy 19,50 € +166% RBC 05/2017 Buy 26,00 € +255% Ch Average: - Buy 20,2 € +176% Of SHAREHOLDERS ADDRESS Shareholder structure 2 (undiluted) 5 rue de la Baume, Public 75008 Paris 35% ___________________ EMAIL Truffle info@abivax.com Capital 60% www.abivax.com Incubator Holding Founders MANAGEMENT TEAM 3% 2% CEO: Prof. Hartmut Ehrlich, M.D. CFO: Didier Blondel As of December 31 st , 2017 CMO: Jean-Marc Steens, M.D. CCO & VP BD: Pierre Courteille PIPELINE TARGETED MARKET Lead generation ____________ Research Preclinical Phase 1 Phase 2 Phase 3 HIV In 3 rd Phase 2 ABX464 • Lasting viral remission HIV: Towards a functional cure for HIV: Targeting RNA splicing Ulcerative Colitis ABX464 In Phase 2 POC • IBD (Ulcerative Colitis & Crohn’s Anti-inflammatory Disease) • Cancer Clinical trial in Immuno-oncology in HCC in ABX196 HCC to start Q4 2018 Immune enhancer combination with checkpoint inhibitors Ebola ABX544 Polyclonal antibodies Dengue LISTED COMPANY Antiviral drug Respiratory Syncytial Virus CREATION DATE Antiviral drug December 2013 Influenza Antiviral drug

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend

Access to antiviral drugs for treating HCV for HIV-positive patients in Russia: results and

Access to antiviral drugs for treating HCV for HIV-positive patients in Russia: results and

Access to antiviral drugs for treating HCV for HIV-positive patients in Russia: results and recommendations of the registration, policy and procurement analysis Babikhina Ksenia Treatment Preparedness Coalition office@itpcru.org

130 views • 11 slides
Hepatitis C: A Rapidly Evolving Paradigm Anita Kohli, MD, MS St. Josephs Hospital and

Hepatitis C: A Rapidly Evolving Paradigm Anita Kohli, MD, MS St. Josephs Hospital and

Hepatitis C: A Rapidly Evolving Paradigm Anita Kohli, MD, MS St. Josephs Hospital and Medical Center Division of Hepatology and Infectious Disease Arizona Infectious Disease Conference Black Canyon Conference Center July 23, 2015

785 views • 29 slides
COVID-19 FAQ Is there a vaccine, drug or treatment for COVID-19? To date, there is no vaccine and

COVID-19 FAQ Is there a vaccine, drug or treatment for COVID-19? To date, there is no vaccine and

COVID-19 FAQ Is there a vaccine, drug or treatment for COVID-19? To date, there is no vaccine and no specific antiviral medicine to prevent or treat COVID- 2019. However, those affected should receive care to relieve symptoms. People with serious

465 views • 15 slides
"Does conducting a pro-environmental lifestyle through eating and growing organic food

"Does conducting a pro-environmental lifestyle through eating and growing organic food

"Does conducting a pro-environmental lifestyle through eating and growing organic food affect the overall health of the participant and the physical health of the environment? If so, why?" Anna Whitted Subclaim 1: The practice of

582 views • 26 slides
therapy in chronic hepatitis B Dr Grace Lai-Hung Wong MBChB (Hons, CUHK), MD (CUHK), MRCP, FHKCP,

therapy in chronic hepatitis B Dr Grace Lai-Hung Wong MBChB (Hons, CUHK), MD (CUHK), MRCP, FHKCP,

International Symposium on Hepatology 2012 & 25th Annual Scientific Meeting New perspective of anti-viral therapy in chronic hepatitis B Dr Grace Lai-Hung Wong MBChB (Hons, CUHK), MD (CUHK), MRCP, FHKCP, FHKAM (Medicine) Associate Professor

321 views • 28 slides
An Introduction to Access to Diagnostics 14:00-14:45 BST 17 June Chair: Dr Greg Martin,

An Introduction to Access to Diagnostics 14:00-14:45 BST 17 June Chair: Dr Greg Martin,

An Introduction to Access to Diagnostics 14:00-14:45 BST 17 June Chair: Dr Greg Martin, Specialist Registrar, Public Health Medicine and Editor-in- Chief of Globalization and Health @ drgregmartin Speakers: Raquel Peck, CEO, World Hepatitis

367 views • 32 slides
BTEC: Analytical Services and Capabilities Nathaniel Hentz, Assistant Director Analytical What is

BTEC: Analytical Services and Capabilities Nathaniel Hentz, Assistant Director Analytical What is

BTEC: Analytical Services and Capabilities Nathaniel Hentz, Assistant Director Analytical What is BTEC? Simulated cGMP facility Education and training Process and analytical services First and largest in the world Advisory board

871 views • 28 slides
JC Virus and The Risk of PML PML is a rare disease of CNS that occurs in patients

JC Virus and The Risk of PML PML is a rare disease of CNS that occurs in patients

Discovery and Development of PML treatments Teresa Compton Vice President, PML and Virology Research Biogen Idec JC Virus and The Risk of PML PML is a rare disease of CNS that occurs in patients immunosuppressed and in patients taking

316 views • 8 slides
Session Viral Hepatitis B & D: Clinical Saturday April 25, 2015 Cihan Yurdaydin, MD 1

Session Viral Hepatitis B & D: Clinical Saturday April 25, 2015 Cihan Yurdaydin, MD 1

Session Viral Hepatitis B & D: Clinical Saturday April 25, 2015 Cihan Yurdaydin, MD 1 2 Optimizing the prenylation inhibitor lonafarnib using ritonavir boosting in patients with chronic delta hepatitis Cihan Yurdaydin, Ramazan

490 views • 29 slides
http://ar.wikipedia.org/wiki / http :// www . masraheon . com / . htm 3 .

http://ar.wikipedia.org/wiki / http :// www . masraheon . com / . htm 3 .

http://ar.wikipedia.org/wiki / http :// www . masraheon . com / . htm 3 . http://ar.wikipedia.org/wiki / 707074 Bibliotheca Alexandrina Compiled by Alaa Mahmoud 7 6 0 . http://ar.wikipedia.org/wiki /

351 views • 14 slides
The Pleasure of Discontent: On Writing in a Medical School Telling Giving information

The Pleasure of Discontent: On Writing in a Medical School Telling Giving information

The Pleasure of Discontent: On Writing in a Medical School Telling Giving information Background Explaining Passive aka exposition Discontent: n. The fact or condition of being dissatisfied with one's circumstances; lack of contentment.

379 views • 25 slides
S et the Bar Low. Be a WINNER every time. Public Power Matters Public Power Matters Innovation

S et the Bar Low. Be a WINNER every time. Public Power Matters Public Power Matters Innovation

S et the Bar Low. Be a WINNER every time. Public Power Matters Public Power Matters Innovation Workforce Advocacy Y our S tory Rates Matter Matters Matters Matters Matters Its the Rates, S tupid! Innovation Matters We must

280 views • 26 slides
EVERGREENS FORTHCOMING TITLES SUMMER 2017 NEW EVERGREENS 27TH JULY 2017 A TALE OF TWO CITIES

EVERGREENS FORTHCOMING TITLES SUMMER 2017 NEW EVERGREENS 27TH JULY 2017 A TALE OF TWO CITIES

EVERGREENS FORTHCOMING TITLES SUMMER 2017 NEW EVERGREENS 27TH JULY 2017 A TALE OF TWO CITIES BY CHARLES DICKENS A brand-new edition of one of Dickenss best-loved works Follows the success of Great Expectations , Hard Times , Oliver Twist

526 views • 21 slides
The Golden Age of Russian Lit A century of realism and reflection When exactly was "The

The Golden Age of Russian Lit A century of realism and reflection When exactly was "The

Courtesy of Google Images The Golden Age of Russian Lit A century of realism and reflection When exactly was "The "Golden Age"? 1830's - 1917 Courtesy of Google Images Most Notable Writers Pushkin - National Poet Gogol -

512 views • 14 slides
The 2013 Top Ten Project Lynette Robertson & Rhonda Seamons The Top Top Ten List from the

The 2013 Top Ten Project Lynette Robertson & Rhonda Seamons The Top Top Ten List from the

The 2013 Top Ten Project Lynette Robertson & Rhonda Seamons The Top Top Ten List from the Book at Barnes & Noble 1. Anna Karenina by Leo Tolstoy 2. Madame Bovary by Gustave Flaubert 3. War and Peace by Leo Tolstoy 4. Lolita by

650 views • 23 slides
STANISLAVSKI PRESENTATION CARRIE COLTON HISTORY OF DIRECTING Best known for his Acting System,

STANISLAVSKI PRESENTATION CARRIE COLTON HISTORY OF DIRECTING Best known for his Acting System,

STANISLAVSKI PRESENTATION CARRIE COLTON HISTORY OF DIRECTING Best known for his Acting System, his disciples, and The Moscow Art Theatre. TIMELINE 1863: Constatin Stanislavski is born into the wealthy family of Alekseyevs. He is born into a time

319 views • 6 slides
Brief presentation Of activities Contents 1 - Sound, music and visual compositions. (1992 -

Brief presentation Of activities Contents 1 - Sound, music and visual compositions. (1992 -

Brief presentation Of activities Contents 1 - Sound, music and visual compositions. (1992 - 2014). 2 - Studio19st sound team discography, multimedia productions & digital audio/video files. (1996 - 2010). 3 - Sound design. (1992 - 2014).

606 views • 26 slides
Building global engagement in research Sources of funding for enabling international research

Building global engagement in research Sources of funding for enabling international research

Building global engagement in research Sources of funding for enabling international research collaborations Jane Nicholson, Head of International Policy, EPSRC Engineering Professors Conference 16 April 2013 Introduction Why we need

640 views • 40 slides
INSTITUTE OF TECHNOLOGY, CARLOW SCHOOL OF BUSINESS DEPARTMENT OF BUSINESS AND MANAGEMENT SUMMER

INSTITUTE OF TECHNOLOGY, CARLOW SCHOOL OF BUSINESS DEPARTMENT OF BUSINESS AND MANAGEMENT SUMMER

INSTITUTE OF TECHNOLOGY, CARLOW SCHOOL OF BUSINESS DEPARTMENT OF BUSINESS AND MANAGEMENT SUMMER EXAMINATIONS 2014 COURSE CODE: CW DATE: Course Title: National Certificate in Business Studies Course Year: 1 Subject: Writing, Presentation

256 views • 10 slides
High Performance Flexible Fabric E lectronics for Megahertz Frequency Communications Yiannis

High Performance Flexible Fabric E lectronics for Megahertz Frequency Communications Yiannis

High Performance Flexible Fabric E lectronics for Megahertz Frequency Communications Yiannis Vardaxoglou, ADVANCED Loughborough THERAPEUTIC MATERIALS LTD University Tilak Dias NTU Rob Seager LU Our purpos e To find the most 3 year

192 views • 15 slides
Critter Control Protecting your Fruit and Trees from Those Pesky Varmints Critter Control

Critter Control Protecting your Fruit and Trees from Those Pesky Varmints Critter Control

Critter Control Protecting your Fruit and Trees from Those Pesky Varmints Critter Control Mammals: Gophers Rats Squirrels Raccoons Rabbits Birds Snails Ants Some common insects and bugs Some common

874 views • 61 slides
BioSIRT .. BioSIRT .. Bio security S urveillance I ncident R esponse & T racing BioSIRT is

BioSIRT .. BioSIRT .. Bio security S urveillance I ncident R esponse & T racing BioSIRT is

BioSIRT .. Short Presentation BioSIRT .. BioSIRT .. Bio security S urveillance I ncident R esponse & T racing BioSIRT is a web enabled, spatial database An informal meeting held in May 2002 discussed the benefits of aligning national

520 views • 17 slides
4-H Presentations 2020 4-H Presentations at A Glance Age Categories: 8-10, 11-13 & 14-18

4-H Presentations 2020 4-H Presentations at A Glance Age Categories: 8-10, 11-13 & 14-18

4-H Presentations 2020 4-H Presentations at A Glance Age Categories: 8-10, 11-13 & 14-18 Animal Science Horse Objective: To increase the level of horse knowledge and expertise. Topics Include: horse selection, feeding, health, management,

366 views • 12 slides
4-H PRESENTATIONS 4-H Presentations What are 4-H Presentations? 4-H Presentations are a huge

4-H PRESENTATIONS 4-H Presentations What are 4-H Presentations? 4-H Presentations are a huge

North Carolina 4-H 4-H PRESENTATIONS 4-H Presentations What are 4-H Presentations? 4-H Presentations are a huge part of North Carolina 4-H. It is one of the most successful way to help a young person learn how to do a public speech. It

746 views • 17 slides

More recommend